Emerging therapies for treating type 2 diabetes

被引：0
|
作者：
Chen, Ying Yin [1 ]
Norwood, Daryn K. [2 ]
机构：
[1] MedStar Union Mem Hosp, Baltimore, MD 21218 USA
[2] MedStar Union Mem Hosp, Pharm Residency Programs, Dept Pharm, Baltimore, MD USA
来源：
FORMULARY | 2013年 / 48卷 / 11期
关键词：
MELLITUS; SAFETY; EFFICACY; CANAGLIFLOZIN; MANAGEMENT;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Type 2 diabetes mellitus presents multiple treatment dilemmas for prescribers and healthcare clinicians. The number of oral agents for treating diabetes has increased over the past decade, and the best treatment regimen for each patient often varies based on comorbid conditions and treatment goals. Hence, understanding the risks and benefits of each agent is vital. While the number of agents for treating type 2 diabetes mellitus continues to increase, prescribers and clinicians may struggle with the need to individualize care as a means to improve treatment outcomes.
引用
收藏
页码：353 / 358
页数：6
相关论文
共 50 条
  • [1] Emerging Therapies for Type 2 Diabetes
    Stonehouse, Anthony H.
    Maggs, David G.
    [J]. CURRENT DRUG THERAPY, 2007, 2 (02) : 151 - 160
  • [2] Current and emerging therapies for type 2 diabetes
    Xu, J
    [J]. IDRUGS, 2004, 7 (03) : 249 - 256
  • [3] Current Therapies and Emerging Drugs in the Pipeline for Type 2 Diabetes
    Nguyen, Quang T.
    Thomas, Karmella T.
    Lyons, Katie B.
    Nguyen, Loida D.
    Plodkowski, Raymond A.
    [J]. AMERICAN HEALTH AND DRUG BENEFITS, 2011, 4 (05): : 303 - 311
  • [4] Novel and emerging diabetes mellitus drug therapies for the type 2 diabetes patient
    Rochester, Charmaine D.
    Akiyode, Oluwaranti
    [J]. WORLD JOURNAL OF DIABETES, 2014, 5 (03): : 305 - 315
  • [5] New and Emerging Pharmacologic Therapies for Type 2 Diabetes, Dyslipidemia, and Obesity
    Taylor, James R.
    Dietrich, Eric
    Powell, Jason G.
    [J]. CLINICAL THERAPEUTICS, 2013, 35 (01) : A3 - A17
  • [6] A Comprehensive Review of Emerging Therapies for Type 2 Diabetes and Their Cardiovascular Effects
    Acosta, G. Arnaldo J.
    Chitneni, Eesha
    Vidals, Claudia Jeanette Manzanares
    Modumudi, Sravani
    Hammad, Sobia
    Verma, Ashee
    Rajesh, Rahul Y.
    Khaliq, Aimen
    Adeyemi, Olaoluwa
    Abid, Farhat
    Gujar, Rucha, V
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [7] Emerging role of insulin with incretin therapies for management of type 2 diabetes
    Ahluwalia R.
    Vora J.
    [J]. Diabetes Therapy, 2011, 2 (3) : 146 - 161
  • [8] Recent developments and emerging therapies for type 2 diabetes mellitus.
    Evans A.J.
    Krentz A.J.
    [J]. Drugs in R & D, 1999, 2 (2) : 75 - 94
  • [9] Current, new, and emerging therapies for managing hyperglycaemia in type 2 diabetes
    Munro, Neil
    [J]. BRITISH JOURNAL OF GENERAL PRACTICE, 2008, 58 (553): : 531 - 533
  • [10] New Approaches to Treating Type 2 Diabetes Mellitus in the ElderlyRole of Incretin Therapies
    Angela M. Abbatecola
    Stefania Maggi
    Giuseppe Paolisso
    [J]. Drugs & Aging, 2008, 25 : 913 - 925
12345